Manhattan Supply Chain Commerce Solutions Provide Platform for Growth at Shanghai Pharma
SHANGHAI and ATLANTA, Nov. 4, 2013 (GLOBE NEWSWIRE) -- Shanghai
Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma), a national
pharmaceutical group headquartered in Shanghai, China, has successfully
deployed the latest version of Manhattan Associates' (Nasdaq:MANH)
Warehouse Management solution (WMS) at a new warehouse facility in
Shanghai, China. This latest project success will enable the
pharmaceutical giant to continue growing in the years ahead as well as
help it get closer to its customers.
Tweet this news! .@manhassocnews supply chain commerce solutions
provide platform for growth at Shanghai Pharma
www.manh.com/news/shanghai-pharma-2013
The highly scalable nature of Manhattan's WMS means Shanghai Pharma is
able to handle extremely high throughput within its new DC, ensuring a
continuous, smooth operation during peak periods. The solution has also
reduced operating costs within the DC and allowed Shanghai Pharma to
improve customer service through improved service levels.
According to Shanghai Pharma's Logistics Department, "We saw improved
benefit from this latest deployment of Manhattan's supply chain
commerce technology. We wanted to establish an advanced supply chain
systems capability that would not just manage the new warehouse and
logistics facilities, but would also serve as an independent, open and
intelligent platform that could drive further improvements in inventory
accuracy, deliver productivity improvements in our warehouses, drive
down costs throughout our distribution network and serve as an enabler
for business growth. We have achieved all of this with the latest
version of Manhattan's industry-leading solutions and technology
platform."
The scalable nature of the Manhattan solution helps Shanghai Pharma
comfortably handle its order processing peaks each week, when
throughput volumes can surge by 200 to 300 per cent. Today, Shanghai
Pharma is processing a daily fulfilment volume of up to 35,000 cases
per day.
Steve Smith, senior vice president, International Operations, at
Manhattan Associates, commented, "With our long-established working
relationship, we have a deep understanding of Shanghai Pharma's
operations, enabling us to provide a fully optimized supply chain
commerce solution that meets the business's needs. We look forward to
continuing our collaboration with Shanghai Pharma as it embarks on the
next phase of its supply chain enhancement project in a warehouse in
Shanghai's Pudong district as well as several other warehouses outside
the city."
Receive up-to-date product, customer and partner news directly from
Manhattan Associates on Twitter and Facebook.
About Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Pharmaceuticals is the only integrated pharmaceutical company
in the PRC that has leading positions in both pharmaceutical product
and distribution markets. It is China's second-largest pharmaceutical
distributor and third-largest pharmaceutical producer. The Group has
adopted an integrated vertical business model and provides solutions in
pharmaceutical manufacturing, distribution, logistics storage and
retail. The Group currently offers more than 800 pharmaceutical
products as well as pharmaceutical distribution and supply chain
services to more than 8,000 hospitals and medical institutions in
China. The Group also operates approximately 1,700 self-operated and
franchise stores nationwide. For more information, please visit
http://english.pharm-sh.com.cn/index.html.
About Manhattan Associates, Inc.
Manhattan Associates brings companies closer to their customers. We
design, build and deliver market-leading Supply Chain Commerce
solutions that drive top-line growth by converging front-end sales with
back-end supply chain execution and efficiency. Our software, platform
technology and unmatched experience help our customers around the world
adapt to the challenges of the omni-channel marketplace. For more
information, please visit www.manh.com.